JAID LYONS: Open Payments
NPI 1154035822 · COLUMBUS, OH. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,332 in 76 payments from 17 companies in 2025. Trend: 2023 $2,849 · 2024 $2,281 · 2025 $1,332
Food & beverage: $1,332
| Company | Payments | Amount |
|---|---|---|
| Boehringer Ingelheim Pharmaceuticals, Inc. | 12 | $217 |
| Novartis Pharmaceuticals Corporation | 17 | $216 |
| Merck Sharp & Dohme LLC | 7 | $158 |
| Bayer Healthcare Pharmaceuticals Inc. | 8 | $157 |
| AstraZeneca Pharmaceuticals LP | 9 | $149 |
| Novo Nordisk Inc | 4 | $74 |
| E.R. Squibb & Sons, L.L.C. | 3 | $55 |
| Amgen Inc. | 3 | $47 |
| ABIOMED | 2 | $43 |
| Regeneron Healthcare Solutions, Inc. | 2 | $40 |
Products named: JARDIANCE, LEQVIO, WAINUA, Adempas, VERQUVO, Wegovy, WINREVAIR, CAMZYOS.
Industry payments across OH — which companies pay providers there.
